An investigation was announced for long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors and officers of Revance Therapeutics, Inc. Investors who are current long term investors in Revance Therapeutics,Investigation announced for Investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) over potential Wrongdoing | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investigation was announced for long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors and officers of Revance Therapeutics, Inc. Investors who are current long term investors in Revance Therapeutics,